Form D · Other

SOLEGEAR BIOPLASTIC TECHNOLOGIES INC.

Vancouver, A1 · CIK 0001655412

Offering snapshot reported Oct 14, 2015 · SEC filing

Reported sold: $10K
Investors reported: 1
Minimum accepted: $0
First sale: Sep 30, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 14, 2015	Initial	$10,000	No comparison	1	SEC filing
Oct 14, 2015	Amendment	$10,000	$0vs Oct 14, 2015	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-249292

In Canadian dollars. $1,460,000 is the maximum amount that could be issued to U.S. purchasers under the exemption, based on a total offering of C$2,000,000 in Canada and the U.S. C$530,000 has been sold to Canadian subscribers as of the date hereof.

Source: Form D, filed Oct 14, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Paul John Antoniadis	Director, Executive
Gary Clifford	Executive
Salil Munjal	Director
Michael Gary Thomson	Director
Jim Albino Zadra	Director

Issuer details

Industry: Other (See others in industry)

Address:

#300 110 West Hastings Street
Vancouver, A1, V6B 1G8